The combination of the HOTAIR-EZH2 disruptor AQB and the LSD1 inhibitor GSK-LSD1 induced cell cycle arrest and apoptosis in GBM cell lines, demonstrating greater antitumor efficacy than either agent alone. Here, KDM1A is linked to glioblastoma.